Wells Fargo & Company Amicus Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 414,589 shares of FOLD stock, worth $3.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
414,589
Previous 610,786 32.12%
Holding current value
$3.95 Million
Previous $6.06 Million 26.92%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$9.55 - $12.09 $1.87 Million - $2.37 Million
-196,197 Reduced 32.12%
414,589 $4.43 Million
Q2 2024

Aug 13, 2024
BUY
$9.04 - $11.75 $2,160 - $2,808
239 Added 0.04%
610,786 $6.06 Million
Q1 2024

May 10, 2024
BUY
$11.43 - $14.24 $452,525 - $563,775
39,591 Added 6.93%
610,547 $7.19 Million
Q4 2023

Feb 09, 2024
SELL
$9.97 - $14.52 $1.26 Million - $1.83 Million
-126,245 Reduced 18.11%
570,956 $8.1 Million
Q3 2023

Nov 13, 2023
SELL
$11.78 - $13.86 $593,134 - $697,864
-50,351 Reduced 6.74%
697,201 $8.48 Million
Q2 2023

Aug 15, 2023
BUY
$10.72 - $13.3 $597,522 - $741,328
55,739 Added 8.06%
747,552 $9.39 Million
Q1 2023

May 12, 2023
BUY
$10.91 - $13.54 $1.61 Million - $2 Million
147,422 Added 27.08%
691,813 $7.67 Million
Q4 2022

Feb 13, 2023
BUY
$9.89 - $12.7 $1.06 Million - $1.37 Million
107,659 Added 24.65%
544,391 $6.65 Million
Q3 2022

Nov 14, 2022
SELL
$9.82 - $12.75 $331,660 - $430,618
-33,774 Reduced 7.18%
436,732 $4.56 Million
Q2 2022

Aug 12, 2022
SELL
$6.23 - $11.12 $915,292 - $1.63 Million
-146,917 Reduced 23.8%
470,506 $5.05 Million
Q1 2022

May 16, 2022
SELL
$7.89 - $12.48 $251,572 - $397,924
-31,885 Reduced 4.91%
617,423 $5.85 Million
Q4 2021

Feb 14, 2022
SELL
$9.82 - $12.44 $997,554 - $1.26 Million
-101,584 Reduced 13.53%
649,308 $7.5 Million
Q3 2021

Nov 15, 2021
BUY
$8.74 - $11.84 $1.95 Million - $2.64 Million
222,725 Added 42.17%
750,892 $7.17 Million
Q2 2021

Aug 16, 2021
SELL
$8.71 - $10.72 $1.23 Million - $1.51 Million
-140,754 Reduced 21.04%
528,167 $5.09 Million
Q1 2021

May 13, 2021
BUY
$9.2 - $23.86 $2.52 Million - $6.55 Million
274,391 Added 69.55%
668,921 $6.61 Million
Q4 2020

Feb 09, 2021
BUY
$13.47 - $24.89 $2.07 Million - $3.83 Million
153,935 Added 63.98%
394,530 $9.11 Million
Q3 2020

Nov 05, 2020
SELL
$12.89 - $15.89 $785,503 - $968,320
-60,939 Reduced 20.21%
240,595 $3.4 Million
Q2 2020

Aug 13, 2020
BUY
$8.86 - $15.69 $407,914 - $722,367
46,040 Added 18.02%
301,534 $4.55 Million
Q1 2020

May 14, 2020
BUY
$6.63 - $11.16 $1.69 Million - $2.85 Million
255,494 New
255,494 $2.36 Million

Others Institutions Holding FOLD

# of Institutions
312
Shares Held
314M
Call Options Held
516K
Put Options Held
833K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.67B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email